Cardiac amyloidosis: a treatable disease, often overlooked

MeSH terms

• Adrenergic beta-Antagonists / adverse effects
• Adrenergic beta-Antagonists / therapeutic use
• Amyloidosis / diagnosis*
• Amyloidosis / drug therapy
• Amyloidosis / genetics
• Amyloidosis / pathology
• Angiotensin Receptor Antagonists / adverse effects
• Angiotensin Receptor Antagonists / therapeutic use
• Angiotensin-Converting Enzyme Inhibitors / adverse effects
• Angiotensin-Converting Enzyme Inhibitors / therapeutic use
• Boronic Acids / therapeutic use
• Bortezomib
• Calcium Channel Blockers / adverse effects
• Calcium Channel Blockers / therapeutic use
• Dexamethasone / therapeutic use
• Diuretics / therapeutic use
• Drug Therapy, Combination
• Female
• Heart Failure / diagnosis*
• Heart Failure / drug therapy
• Heart Failure / genetics
• Heart Failure / pathology
• Humans
• Lenalidomide
• Melphalan / therapeutic use
• Middle Aged
• Myocardium / pathology
• Prealbumin / genetics
• Pyrazines / therapeutic use
• Severity of Illness Index
• Stem Cell Transplantation
• Thalidomide / analogs & derivatives
• Thalidomide / therapeutic use
• Treatment Outcome